Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ:VSACU, VSAC, VSACW) (the “Company” or “VSAC”), a special purpose acquisition company, announced today that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with Mediforum Co., Ltd (“Mediforum”), a prominent biotechnology company based in Korea, specializing in the research and development of ethical drugs, diagnostic reagents, and strategic application products, providing for a proposed business combination that, if consummated, will result in Mediforum becoming a publicly listed company. Subject to the terms and conditions set forth in the Merger Agreement, upon the closing of the transactions, the combined company will be listed on NASDAQ under a new ticker symbol.
Related news for (VSAC)
- vision sensing acquisition corp. announces securities suspension date and redemption amount
- vision sensing acquisition corp. announces delisting and subsequent liquidation
- vision sensing acquisition corp. announces intention to extend the period to consummate its initial business combination to november 3, 2024
- vision sensing acquisition corp. announces intention to extend the period to consummate its initial business combination to october 3, 2024
- vision sensing acquisition corp. announces letter of intent with convergence ct, inc.